Synopsis:
2023 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a straightforward style with approachable terminology, it offers concise and consistently formatted drug entries organized alphabetically.
The 2023 Nurse’s Drug Handbook includes:
• Index of all generic, trade, and alternate drug names
• Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule
• Indications and dosages, as well as route, onset, peak, and duration information
• Incompatibilities and contraindications
• Interactions with drugs, food, and activities
• Adverse reactions
• Nursing considerations, including key teaching points for patients
• Mechanism-of-action illustrations
• Warnings and precautions
• Updated appendices, including Uncommon Drugs
• Bolded life-threatening Adverse Drug Reactions (ADRs)
New drugs added to the 2023 Nurse’s Drug Handbook include: Aducanumab-avwa, Atogepant, Baricitini, Cabotegravi, Dasiglucagon, Difelikefalin, Evinacumab-dgnb, Finerenone, Ibrexafungerp, Inclisiran, Molnupiravir, Nirmatrelvir, Ponesimod, Tezepelumab-ekko, Tralokinumab-ldrm, Vericiguat.
|